📣 VC round data is live. Check it out!

Philip Morris Valuation Multiples

Discover revenue and EBITDA valuation multiples for Philip Morris and similar public comparables like British American Tobacco, Altria Group, Japan Tobacco, ITC and more.

Philip Morris Overview

About Philip Morris

Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets.


Founded

1987

HQ

United States

Employees

84.9K

Website

pmi.com

Sectors

Financials (LTM)

Revenue: $42B
EBITDA: $18B

EV

$341B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Philip Morris Financials

Philip Morris reported last 12-month revenue of $42B and EBITDA of $18B.

In the same LTM period, Philip Morris generated $28B in gross profit, $18B in EBITDA, and $12B in net income.

Revenue (LTM)


Philip Morris P&L

In the most recent fiscal year, Philip Morris reported revenue of $41B and EBITDA of $18B.

Philip Morris is profitable as of last fiscal year, with gross margin of 67%, EBITDA margin of 44%, and net margin of 29%.

See analyst estimates for Philip Morris
LTMLast FY202320242025202620272028
Revenue$42B$41B$35B$38B$41B
Gross Profit$28B$27B$22B$25B$27B
Gross Margin67%67%63%65%67%
EBITDA$18B$18B$13B$16B$17B
EBITDA Margin44%44%38%42%43%
EBIT Margin41%40%35%35%37%
Net Profit$12B$12B$8B$7B$11B
Net Margin29%29%22%19%28%
Net Debt—$44B———

Financial data powered by Morningstar, Inc.

Philip Morris Stock Performance

Philip Morris has current market cap of $295B, and enterprise value of $341B.

Market Cap Evolution


Philip Morris' stock price is $188.99.

Philip Morris share price increased by 14.5% in the last 30 days, and by 4.7% in the last year.

Philip Morris has an EPS (earnings per share) of $7.54.

See more trading valuation data for Philip Morris
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$341B$295B0.3%14.5%1.2%4.7%$7.54

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Philip Morris Valuation Multiples

Philip Morris trades at 8.2x EV/Revenue multiple, and 18.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Philip Morris

EV / Revenue (LTM)


Philip Morris Financial Valuation Multiples

As of May 23, 2026, Philip Morris has market cap of $295B and EV of $341B.

Philip Morris has a P/E ratio of 24.0x.

LTMLast FY202320242025202620272028
EV/Revenue8.2x8.4x9.7x9.0x8.4x
EV/EBITDA18.5x19.2x25.5x21.7x19.5x
EV/EBIT20.1x20.8x27.9x25.4x22.8x
EV/Gross Profit12.1x12.5x15.3x13.9x12.5x
P/E24.0x25.1x37.7x41.7x26.0x
EV/FCF—32.0x43.3x31.7x32.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Philip Morris Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Philip Morris Margins & Growth Rates

Philip Morris grew revenue by 7% and EBITDA by 9% in the last fiscal year.

In the most recent fiscal year, Philip Morris reported gross margin of 67%, EBITDA margin of 44%, and net margin of 29%.

See estimated margins and future growth rates for Philip Morris

Philip Morris Margins

Last FY202420252026202720282029
Gross Margin67%65%67%68%
EBITDA Margin44%42%43%45%
EBIT Margin40%35%37%41%
Net Margin29%19%28%30%
FCF Margin26%28%26%30%

Philip Morris Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%8%7%7%
Gross Profit Growth8%10%11%8%
EBITDA Growth9%18%11%11%
EBIT Growth9%10%11%20%
Net Profit Growth11%(10%)61%15%
FCF Growth22%37%(1%)22%

Data powered by FactSet, Inc. and Morningstar, Inc.

Philip Morris Operational KPIs

Philip Morris' revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.

Philip Morris' Rule of 40 is 52% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Philip Morris' Rule of X is 63% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Philip Morris
LTMLast FY202320242025202620272028
Rule of 4051%52%———
Bessemer Rule of X61%63%———
Revenue per Employee—$0.5M———
Opex per Employee—$0.1M———
S&M Expenses to Revenue26%27%——27%
Opex to Revenue—30%29%29%30%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Philip Morris Competitors

Philip Morris competitors include British American Tobacco, Altria Group, Japan Tobacco, ITC, Imperial Brands, KT&G, Smoore International and Godfrey Phillips India.

Most Philip Morris public comparables operate across Tobacco.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
British American Tobacco5.1x5.1x9.7x10.9x
Altria Group7.2x7.1x11.0x11.0x
Japan Tobacco3.3x3.3x10.6x10.7x
ITC4.5x4.9x11.9x14.3x
Imperial Brands1.0x3.3x7.5x7.5x
KT&G2.9x2.9x10.9x11.5x

This data is available for Pro users. Sign up to see all Philip Morris competitors and their valuation data.

Start Free Trial

Philip Morris M&A Activity

Philip Morris has acquired 5 companies to date.

Last acquisition by Philip Morris was on July 18th 2023. Philip Morris acquired Syqe Medical for $650M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Philip Morris

Syqe Medical
Swedish Match
OtiTopic
Vectura
Description
Syqe Medical is a Tel Aviv-based medical device company developing the Syqe Inhaler, a precision metered-dose cannabis vaporizer for therapeutic delivery. FDA-cleared for pulmonary administration, it enables individualized dosing for conditions like chronic pain. Syqe advances botanical drug decentralization through clinical validation and regulatory approvals.
Swedish Match is a tobacco products manufacturer headquartered in Stockholm. The company produces snus and nicotine pouches under brands like General and ZYN, alongside cigars such as Game and Just for Him, chewing tobacco, and matches with Swan and Feudor labels. Listed on Nasdaq Stockholm, it distributes in over 100 countries with a strong presence in Scandinavia and the United States. Swedish Match focuses on smoke-free oral nicotine products and maintains leadership in the snus category across Northern Europe.
OtiTopic is a pharmaceutical services provider focused on drug delivery systems and drug-device combination product development. The company offers formulation expertise, device engineering, and regulatory support for nasal, inhaled, and topical therapies. OtiTopic collaborates with biotech firms to advance complex molecules toward clinical and commercial stages.
—
HQ CountryIsraelSwedenUnited StatesUnited Kingdom
HQ City
Tel Aviv
Stockholm
Los Angeles, CA
—
Deal Date18 Jul 202311 May 20229 Aug 20219 Jul 2021
Valuation$650M$16B$51M$1B
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Philip Morris acquisitions and their M&A valuation multiples.

Start Free Trial

Philip Morris Investment Activity

Philip Morris has invested in 2 companies to date.

Latest investment by Philip Morris was on September 16th 2019. Philip Morris invested in AutoX in their $100M Series A round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Philip Morris

AutoX
Syqe Medical
Description
—
Syqe Medical is a Tel Aviv-based medical device company developing the Syqe Inhaler, a precision metered-dose cannabis vaporizer for therapeutic delivery. FDA-cleared for pulmonary administration, it enables individualized dosing for conditions like chronic pain. Syqe advances botanical drug decentralization through clinical validation and regulatory approvals.
HQ CountryUnited StatesIsrael
HQ City
—
Tel Aviv
Deal Date16 Sep 201919 Jan 2016
RoundSeries AUndisclosed stage
Raised$100M$20M
InvestorsDongfeng Motor Group Co; Philip Morris; Plug and Play; SinarmasPhilip Morris
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Philip Morris investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Philip Morris

When was Philip Morris founded?Philip Morris was founded in 1987.
Where is Philip Morris headquartered?Philip Morris is headquartered in United States.
How many employees does Philip Morris have?As of today, Philip Morris has over 84K employees.
Who is the CEO of Philip Morris?Philip Morris' CEO is Jacek Olczak.
Is Philip Morris publicly listed?Yes, Philip Morris is a public company listed on NYSE.
What is the stock symbol of Philip Morris?Philip Morris trades under PM ticker.
When did Philip Morris go public?Philip Morris went public in 2008.
Who are competitors of Philip Morris?Philip Morris main competitors include British American Tobacco, Altria Group, Japan Tobacco, ITC, Imperial Brands, KT&G, Smoore International, Godfrey Phillips India.
What is the current market cap of Philip Morris?Philip Morris' current market cap is $295B.
What is the current revenue of Philip Morris?Philip Morris' last 12 months revenue is $42B.
What is the current revenue growth of Philip Morris?Philip Morris revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Philip Morris?Current revenue multiple of Philip Morris is 8.2x.
Is Philip Morris profitable?Yes, Philip Morris is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Philip Morris?Philip Morris' last 12 months EBITDA is $18B.
What is Philip Morris' EBITDA margin?Philip Morris' last 12 months EBITDA margin is 44%.
What is the current EV/EBITDA multiple of Philip Morris?Current EBITDA multiple of Philip Morris is 18.5x.
How many companies Philip Morris has acquired to date?As of May 2026, Philip Morris has acquired 5 companies.
What was the largest acquisition by Philip Morris?$16B acquisition of Swedish Match on 11th May 2022 was the largest M&A Philip Morris has done to date.
What companies Philip Morris acquired?Philip Morris acquired Swedish Match, Vectura, Fertin Pharma, Syqe Medical, and OtiTopic.
In how many companies Philip Morris has invested to date?As of May 2026, Philip Morris has invested in 2 companies.
What was the last Philip Morris investment?On 16th September 2019 Philip Morris invested in AutoX, participating in a $100M Series A round, alongside Dongfeng Motor Group Co, Plug and Play, and Sinarmas.
In what companies Philip Morris invested in?Philip Morris invested in AutoX and Syqe Medical.

See public comps similar to Philip Morris

Lists including Philip Morris

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial